CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Gan & Lee und die Menarini Group schließen Partnerschaft zur Weiterentwicklung von Bofanglutide in Europa

PartnershipBofanglutidePositive
AI Analysis

Summary

Gan & Lee Pharmaceuticals has entered into an exclusive licensing agreement with The Menarini Group for the development and commercialization of Bofanglutide in Europe.

Importance:7/10
Sentiment:
0.60
partnershiplicensingEuropeGan & LeeMenarini
Related Companies

Read the original article

Published by PR Newswire Biotech on September 3, 2026 5:04 PM

Read Original